Subscribe To
Bitcoin price could reach $150,000 by 2025, bernstein says
The research arm of wealth manager AllianceBernstein is predicting a five-fold increase in bitcoin’s ...
November 2, 2023, 2:29 pm
Karyopharm therapeutics inc. (kpti) q3 2023 earnings conference call transcript
Karyopharm Therapeutics Inc. (NASDAQ:KPTI ) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM E...
November 2, 2023, 2:25 pm
American water (awk) q3 earnings & revenues surpass estimates
American Water (AWK) third-quarter earnings are better than expected as the company benefits from warm ...
November 2, 2023, 1:33 pm
United states nonfarm unit labour cost
Labour Costs in the United States decreased to 119.69 points in the third quarter of 2023 from 119.93 points in the second quarter of 2023. Read Full ...
November 2, 2023, 12:39 pm
United states nonfarm labour productivity
Productivity in the United States increased to 110.85 points in the third quarter of 2023 from 109.57 points in the second quarter of 2023. Read Full ...
November 2, 2023, 12:39 pm
Aurinia pharmaceuticals inc. (auph) q3 2023 earnings call transcript
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH ) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM E...
November 2, 2023, 12:06 pm
Assertio holdings, inc. to release third quarter 2023 financial results on november 8, 2023
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty ph...
November 2, 2023, 12:06 pm
Shell exits us southcoast wind farm contract, agrees to pay penalty
Shell's finance chief said on Thursday the firm had exited a power purchase agreement (PPA) for the planned SouthCoast windf...
November 2, 2023, 11:45 am
Optimi health announces third and final tranche of cad $1,000,000 secured for debt financing
is pleased to announce it has entered into a non-dilutive Debt Financing Agreement (“DFA”) and General Security Agreement (“GSA”) for total pr...
November 2, 2023, 11:44 am
Kura oncology and mirati therapeutics enter into clinical collaboration and supply agreement to evaluate ko-2806 and adagrasib in krasᴳ¹²ᶜ-mutated nsclc
– Ongoing Phase 1 dose-escalation trial of KO-2806 (FIT-001) expected to begin dosing patients in combination with adagrasib by mid-2024 – SAN DIE...
November 2, 2023, 11:30 am
Clearside biomedical announces presentations at the american academy of ophthalmology 2023 annual meeting
– Clinical Data Utilizing Clearside’s Suprachoroidal Delivery Technology to be Featured in Multiple Oral and Poster Presentations – ALPHARETTA, ...
November 2, 2023, 11:05 am
Gsk falls victim of ‘hard to please' pharma market
GSK PLC (LSE:GSK, NYSE:GSK)'s seemingly positive earnings release on Wednesday has been labelled as just that by Stifel analysts, who were left mullin...
November 2, 2023, 11:02 am
Here is what to know beyond why armour residential reit, inc. (arr) is a trending stock
Zacks.com users have recently been watching armour Residential REIT (ARR) quite a bit. Thus, it is wort...
November 2, 2023, 10:34 am
David harris jr. appointed as global warming solutions’ spokesperson to power the planet’s transition to clean energy
Temecula, CA , Nov. 02, 2023 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc. (GWSO), a worldwide de...
November 2, 2023, 10:00 am
This high-yield dividend stock is a proven wealth creator
In 2023, the broader market has ignored the deep value proposition of most large-cap pharmaceutical sto...
November 2, 2023, 10:00 am
In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceut...
November 2, 2023, 9:17 am
Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition
BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a c...
November 2, 2023, 9:15 am
Vincerx pharma to present three posters at ash 2023 in december
VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...
November 2, 2023, 9:10 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am
Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato
BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today ...
November 2, 2023, 9:09 am